Cargando…

Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia

Background: During the initiation of treatment of a chronic disease, patients may have varying interests, expectations, concerns, and reasons to stop treatment, influencing compliance with prescribed treatment. Thus, healthcare professionals are expected to integrate these needs into medicines manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Vučićević, Katarina M., Miljković, Branislava R., Golubović, Bojana C., Jovanović, Marija N., Vezmar Kovačević, Sandra D., Ćulafić, Milica D., Kovačević, Milena M., de Gier, Johan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774285/
https://www.ncbi.nlm.nih.gov/pubmed/29164957
http://dx.doi.org/10.1080/13814788.2017.1388778
_version_ 1783293729550893056
author Vučićević, Katarina M.
Miljković, Branislava R.
Golubović, Bojana C.
Jovanović, Marija N.
Vezmar Kovačević, Sandra D.
Ćulafić, Milica D.
Kovačević, Milena M.
de Gier, Johan J.
author_facet Vučićević, Katarina M.
Miljković, Branislava R.
Golubović, Bojana C.
Jovanović, Marija N.
Vezmar Kovačević, Sandra D.
Ćulafić, Milica D.
Kovačević, Milena M.
de Gier, Johan J.
author_sort Vučićević, Katarina M.
collection PubMed
description Background: During the initiation of treatment of a chronic disease, patients may have varying interests, expectations, concerns, and reasons to stop treatment, influencing compliance with prescribed treatment. Thus, healthcare professionals are expected to integrate these needs into medicines management. Objectives: To determine what information is important to patients; assess predictors of patients’ interests, expectations, concerns, reasons to stop therapy; evaluate drug-related problems following initiation of therapy and summarize how pharmacists resolve them during patient–pharmacist counselling. Methods: In 2014, a four-month study was performed in Serbian community pharmacies, as part of the Pharmaceutical Care Quality Indicators Project led by the European Directorate for the Quality of Medicines & Healthcare. Seventy community pharmacists were asked to participate in the study. Pharmacists recruited adult patients who consented to participate in the study and who initiated treatment, lasting at least six months. Patients completed an open-ended questions form. After two-to-four weeks, a patient–pharmacist consultation was performed. Results: Forty-four community pharmacists (response rate 62.9%) sent back the completed forms from 391 patients (response rate 67.1%). The total number of dispensed drugs was 403. In terms of drug safety, 29.4% of patients sought information, 32.5% expressed concerns, and 28.1% of patients cited it as a reason to discontinue treatment. During the first weeks of therapy, 18% of patients experienced practical problems, while 27.3% reported adverse drug reactions. Conclusion: Safety issues are a major focus of patients’ prescribed new medicines for long-term treatment.
format Online
Article
Text
id pubmed-5774285
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-57742852018-02-28 Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia Vučićević, Katarina M. Miljković, Branislava R. Golubović, Bojana C. Jovanović, Marija N. Vezmar Kovačević, Sandra D. Ćulafić, Milica D. Kovačević, Milena M. de Gier, Johan J. Eur J Gen Pract Original Article Background: During the initiation of treatment of a chronic disease, patients may have varying interests, expectations, concerns, and reasons to stop treatment, influencing compliance with prescribed treatment. Thus, healthcare professionals are expected to integrate these needs into medicines management. Objectives: To determine what information is important to patients; assess predictors of patients’ interests, expectations, concerns, reasons to stop therapy; evaluate drug-related problems following initiation of therapy and summarize how pharmacists resolve them during patient–pharmacist counselling. Methods: In 2014, a four-month study was performed in Serbian community pharmacies, as part of the Pharmaceutical Care Quality Indicators Project led by the European Directorate for the Quality of Medicines & Healthcare. Seventy community pharmacists were asked to participate in the study. Pharmacists recruited adult patients who consented to participate in the study and who initiated treatment, lasting at least six months. Patients completed an open-ended questions form. After two-to-four weeks, a patient–pharmacist consultation was performed. Results: Forty-four community pharmacists (response rate 62.9%) sent back the completed forms from 391 patients (response rate 67.1%). The total number of dispensed drugs was 403. In terms of drug safety, 29.4% of patients sought information, 32.5% expressed concerns, and 28.1% of patients cited it as a reason to discontinue treatment. During the first weeks of therapy, 18% of patients experienced practical problems, while 27.3% reported adverse drug reactions. Conclusion: Safety issues are a major focus of patients’ prescribed new medicines for long-term treatment. Taylor & Francis 2017-11-22 /pmc/articles/PMC5774285/ /pubmed/29164957 http://dx.doi.org/10.1080/13814788.2017.1388778 Text en © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Vučićević, Katarina M.
Miljković, Branislava R.
Golubović, Bojana C.
Jovanović, Marija N.
Vezmar Kovačević, Sandra D.
Ćulafić, Milica D.
Kovačević, Milena M.
de Gier, Johan J.
Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia
title Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia
title_full Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia
title_fullStr Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia
title_full_unstemmed Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia
title_short Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia
title_sort expectations, concerns, and needs of patients who start drugs for chronic conditions. a prospective observational study among community pharmacies in serbia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774285/
https://www.ncbi.nlm.nih.gov/pubmed/29164957
http://dx.doi.org/10.1080/13814788.2017.1388778
work_keys_str_mv AT vucicevickatarinam expectationsconcernsandneedsofpatientswhostartdrugsforchronicconditionsaprospectiveobservationalstudyamongcommunitypharmaciesinserbia
AT miljkovicbranislavar expectationsconcernsandneedsofpatientswhostartdrugsforchronicconditionsaprospectiveobservationalstudyamongcommunitypharmaciesinserbia
AT golubovicbojanac expectationsconcernsandneedsofpatientswhostartdrugsforchronicconditionsaprospectiveobservationalstudyamongcommunitypharmaciesinserbia
AT jovanovicmarijan expectationsconcernsandneedsofpatientswhostartdrugsforchronicconditionsaprospectiveobservationalstudyamongcommunitypharmaciesinserbia
AT vezmarkovacevicsandrad expectationsconcernsandneedsofpatientswhostartdrugsforchronicconditionsaprospectiveobservationalstudyamongcommunitypharmaciesinserbia
AT culaficmilicad expectationsconcernsandneedsofpatientswhostartdrugsforchronicconditionsaprospectiveobservationalstudyamongcommunitypharmaciesinserbia
AT kovacevicmilenam expectationsconcernsandneedsofpatientswhostartdrugsforchronicconditionsaprospectiveobservationalstudyamongcommunitypharmaciesinserbia
AT degierjohanj expectationsconcernsandneedsofpatientswhostartdrugsforchronicconditionsaprospectiveobservationalstudyamongcommunitypharmaciesinserbia